Clinical trials
Lung Diseases trials in Canada with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2011 | 2 |
| 2013 | 2 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 5 |
| 2023 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 14 |
| Recruiting | 2 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Health Network, Toronto | 2 |
| University of Alberta | 2 |
| University of British Columbia | 2 |
| Western University, Canada | 2 |
| 1QB Information Technologies Inc. | 1 |
| Centre hospitalier de l'Université de Montréal (CHUM) | 1 |
| Hôpital de Verdun | 1 |
| Laval University | 1 |
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 1 |
| Olympus Corporation of the Americas | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Diseases | 21 |
| Cystic Fibrosis | 4 |
| Respiratory Tract Diseases | 4 |
| Dyspnea | 3 |
| Pathologic Processes | 3 |
| Pulmonary Disease, Chronic Obstructive | 3 |
| Disease | 2 |
| Lung Neoplasms | 2 |
| Neoplasms | 2 |
| Bronchopulmonary Dysplasia | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.